Oncternal Therapeutics, Inc.
ONCT · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,464 | -$8,559 | -$8,388 | -$9,164 |
| Dep. & Amort. | $0 | $0 | $0 | $329 |
| Deferred Tax | $0 | $0 | $0 | $112 |
| Stock-Based Comp. | $1,854 | $1,382 | $1,360 | $2,218 |
| Change in WC | -$1,404 | $1,539 | -$135 | $869 |
| Other Non-Cash | $1,061 | $757 | $771 | -$342 |
| Operating Cash Flow | -$6,953 | -$5,822 | -$7,438 | -$6,419 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$6,292 | -$10,026 | -$11,808 |
| Inv. Sales/Matur. | $13,650 | $12,100 | $17,250 | $10,000 |
| Other Inv. Act. | $0 | $5,808 | $7,224 | -$1,808 |
| Investing Cash Flow | $13,650 | $5,808 | $7,224 | -$1,808 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$87 | -$1 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | -$87 | -$1 |
| Forex Effect | $0 | $0 | $0 | $2,581 |
| Net Chg. in Cash | $6,697 | -$14 | -$301 | -$8,228 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,382 | $6,396 | $6,697 | $14,925 |
| End Cash | $13,079 | $6,382 | $6,396 | $6,697 |
| Free Cash Flow | -$6,953 | -$5,822 | -$7,438 | -$6,419 |